Small Cell Lung Cancer: What is the Role of IO Therapy in the Frontline Setting?
A brief review of the role that immunotherapy agents play in the frontline management of patients with small cell lung cancer.
Source: onclive.com
Survival Data News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Survival Data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Survival Data Today - Breaking & Trending Today
First Report of PhALLCON: A Phase 3 Study Comparing Ponatinib vs Imatinib in Newly Diagnosed Ph+ ALL
Expert Elias Jabbour, MD, reviews clinical data from the PhALLCON study of ponatinib vs imatinib in patients with Ph+ acute lymphocytic leukemia and considers its clinical implications.
Source: onclive.com
Metastatic Hormone-Sensitive Prostate Cancer: Data From ENZAMET and ARCHES
Shared insight on the ENZAMET and ARCHES clinical trials, which utilized combination enzalutamide strategies in patients with metastatic hormone-sensitive prostate cancer.
Source: onclive.com
nmCRPC: Clinical Trial Data on AR Inhibitors
Shared insight on the SPARTAN, PROSPER, and ARAMIS studies with androgen receptor (AR) inhibitors in non-metastatic castration-resistant prostate cancer.
Source: onclive.com
Blueprint Medicines Reports Continued Progress Toward Goal of Transforming Treatment of Systemic Mastocytosis
-- New analyses showing AYVAKIT® (avapritinib) significantly improved overall survival in advanced SM, when indirectly compared to real-world data for prior...
Source: prnewswire.com